Provided by Tiger Trade Technology Pte. Ltd.

Cardiol Therapeutics Inc

1.10
-0.0500-4.35%
Post-market: 1.100.0024+0.22%19:30 EDT
Volume:631.73K
Turnover:697.33K
Market Cap:134.20M
PE:-4.66
High:1.14
Open:1.14
Low:1.09
Close:1.15
52wk High:2.34
52wk Low:0.8800
Shares:122.00M
Float Shares:96.67M
Volume Ratio:0.48
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2360
EPS(LYR):-0.2835
ROE:-190.18%
ROA:-90.92%
PB:7.91
PE(LYR):-3.88

Loading ...

Cardiol Therapeutics receives over $7M in proceeds from warrant exercise

TIPRANKS
·
Sep 16

Press Release: Cardiol Therapeutics Announces Warrant Exercise for over USD $7 Million in Proceeds

Dow Jones
·
Sep 16

Cardiol Therapeutics files $150M preliminary base shelf prospectus

TIPRANKS
·
Sep 11

Cardiol Therapeutics initiated with a Buy at B. Riley

TIPRANKS
·
Aug 26

Cardiol Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Wall Street Analysts Are Bullish on Top Healthcare Picks

TIPRANKS
·
Aug 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Aug 13

Cardiol Therapeutics Inc Expected to Post a Loss of 8 Cents a Share - Earnings Preview

Reuters
·
Aug 11

H.C. Wainwright Remains a Buy on Cardiol Therapeutics (CRDL)

TIPRANKS
·
Jul 15

Press Release: Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders

Dow Jones
·
Jun 25

H.C. Wainwright Keeps Their Buy Rating on Cardiol Therapeutics (CRDL)

TIPRANKS
·
May 27

Cardiol Therapeutics Inc expected to post a loss of 8 cents a share - Earnings Preview

Reuters
·
May 09

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Alzamend Neuro (ALZN) and Cardiol Therapeutics (CRDL)

TIPRANKS
·
Apr 08

Cardiol Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
Apr 01

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 30

Cardiol Therapeutics Inc expected to post a loss of 10 cents a share - Earnings Preview

Reuters
·
Mar 28

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Mar 27